Brand name
Oxbryta, the original
We didn’t find a savings card or cash price from Oxbryta’s maker. Ask the pharmacy for Oxbryta’s cash price. With insurance, ask what your plan charges.
Generic name: voxelotor
Used for: Sickle cell disease
Ask for the cash price
Oxbryta
We didn’t find one.
Oxbryta, the original
We didn’t find a savings card or cash price from Oxbryta’s maker. Ask the pharmacy for Oxbryta’s cash price. With insurance, ask what your plan charges.
There isn’t one.
We didn’t find one.
OXBRYTA is a hemoglobin S polymerization inhibitor indicated for the treatment of sickle cell disease in adults and pediatric patients 4 years of age and older. This indication is approved under accelerated approval based on increase in hemoglobin (Hb). Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trial(s).
Source: the FDA label for Oxbryta (Global Blood Therapeutics, Inc, A subsidiary of Pfizer Inc.), December 26, 2023. Full label on DailyMed
Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/oxbryta/